Učitavanje...

Efficacy and Safety of Secukinumab in Elderly Subjects with Moderate to Severe Plaque Psoriasis: A Pooled Analysis of Phase III Studies

BACKGROUND: Psoriasis is a chronic inflammatory skin disease, affecting patients of a wide age range, including elderly patients. Elderly patients can respond differently to drug treatments and can be more vulnerable to adverse reactions. There are limited data on biologic therapies for psoriasis in...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Drugs Aging
Glavni autori: Körber, Andreas, Papavassilis, Charis, Bhosekar, Vaishali, Reinhardt, Maximilian
Format: Artigo
Jezik:Inglês
Izdano: Springer International Publishing 2018
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5847154/
https://ncbi.nlm.nih.gov/pubmed/29404966
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40266-018-0520-z
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!